Search for: "Deas v. Deas" Results 521 - 540 of 825
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Sep 2021, 12:00 pm by Caitlin Lentz
  While the PHE continues, the exception will apply and provides as follows: “DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional… [read post]
3 Mar 2011, 2:33 pm by James Bickford
At Monday’s oral argument in DePierre v. [read post]
14 Jun 2023, 8:38 am by Levin Papantonio
Walgreens liability depositions taken by Mougey and Gaddy have played in every trial against Walgreens in federal and state court.New Mexico v. [read post]
3 Aug 2011, 8:25 am by McNabb Associates, P.C.
Corso, Special Agent in Charge of DEA’s Detroit Field Division stated, “Confronting the illegal diversion and abuse of controlled pharmaceuticals is a top priority of DEA and our law enforcement partners. [read post]
16 Jun 2022, 10:05 am by James Kachmar
The Ninth Circuit recently tackled this issue in AK Futures LLC v. [read post]
14 Aug 2017, 10:13 am by Jonathan H. Adler
Such concerns are likely overstated, as Alabama argued in its powerful Gonzales v. [read post]